Variant report

Variant	rs2021734
Chromosome Location	chr3:50193383-50193384
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	GTF2F1	chr3:50193346-50193673	Hela-S3	cervix:	n/a	n/a
2	REST	chr3:50191706-50193577	H1-neurons	neurons:	n/a	chr3:50192632-50192645 chr3:50193092-50193102 chr3:50192628-50192648 chr3:50193114-50193124 chr3:50192001-50192014 chr3:50192628-50192648
3	TAF1	chr3:50193276-50193560	H1-hESC	embryonic stem cell:	n/a	n/a
4	POLR2A	chr3:50193127-50193562	PANC-1	pancreas:	n/a	n/a
5	CHD1	chr3:50192283-50194228	IMR90	lung:	n/a	n/a
6	POLR2A	chr3:50193320-50193469	Hela-S3	cervix:	n/a	n/a
7	CHD2	chr3:50193270-50193424	Hela-S3	cervix:	n/a	n/a
8	POLR2A	chr3:50193146-50193890	HUVEC	blood vessel:	n/a	n/a
9	POLR2A	chr3:50192910-50193676	H1-neurons	neurons:	n/a	n/a
10	POLR2A	chr3:50193303-50193526	H1-hESC	embryonic stem cell:	n/a	n/a
11	SMARCB1	chr3:50192068-50193631	Hela-S3	cervix:	n/a	n/a
12	TFAP2A	chr3:50192788-50193770	Hela-S3	cervix:	n/a	chr3:50192904-50192912 chr3:50192904-50192912 chr3:50193112-50193124 chr3:50192904-50192912
13	POLR2A	chr3:50193170-50193694	MCF-7	breast:	n/a	n/a
14	ZBTB7A	chr3:50192925-50193642	ECC-1	luminal epithelium:	n/a	chr3:50193047-50193056
15	POLR2A	chr3:50193072-50193672	Hela-S3	cervix:	n/a	n/a
16	POLR2A	chr3:50192970-50195122	HUVEC	blood vessel:	n/a	n/a
17	POLR2A	chr3:50193127-50194992	HUVEC	blood vessel:	n/a	n/a
18	ZBTB7A	chr3:50192488-50193851	ECC-1	luminal epithelium:	n/a	chr3:50193798-50193806 chr3:50192719-50192728 chr3:50193047-50193056
19	POLR2A	chr3:50192198-50195021	HUVEC	blood vessel:	n/a	n/a
20	POLR2A	chr3:50193314-50193559	H1-hESC	embryonic stem cell:	n/a	n/a
21	POLR2A	chr3:50193162-50193545	MCF-7	breast:	n/a	n/a
22	POLR2A	chr3:50193224-50193681	IMR90	lung:	n/a	n/a
23	SMC3	chr3:50191268-50193403	SK-N-SH	brain:	n/a	chr3:50191660-50191668 chr3:50192013-50192023 chr3:50192717-50192727 chr3:50192013-50192027
24	TFAP2C	chr3:50192595-50193812	Hela-S3	cervix:	n/a	n/a
25	POLR2A	chr3:50193189-50193559	MCF-7	breast:	n/a	n/a
26	RCOR1	chr3:50193368-50193435	Hela-S3	cervix:	n/a	n/a
27	MAZ	chr3:50191779-50196044	IMR90	lung:	n/a	chr3:50194117-50194127 chr3:50193018-50193028 chr3:50195301-50195311 chr3:50195294-50195304 chr3:50193111-50193121
28	SIN3A	chr3:50192435-50193680	H1-hESC	embryonic stem cell:	n/a	chr3:50192471-50192484 chr3:50193118-50193131
29	POLR2A	chr3:50193204-50193711	H1-neurons	neurons:	n/a	n/a
30	MAX	chr3:50193149-50193477	Hela-S3	cervix:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:50191641..50194297-chr3:50220054..50223610,4	MCF-7	breast:
2	chr3:50190470..50194491-chr3:50196225..50201802,7	K562	blood:
3	chr3:50191627..50193691-chr3:50209687..50211278,2	MCF-7	breast:
4	chr3:50192650..50196663-chr3:50219720..50222472,4	MCF-7	breast:
5	chr3:50149445..50151714-chr3:50193369..50195764,2	MCF-7	breast:
6	chr3:50192501..50194771-chr3:50274192..50275707,2	MCF-7	breast:
7	chr3:50191401..50200098-chr3:50206213..50213809,14	MCF-7	breast:

Variant related genes	Relation type
SEMA3F	TF binding region
ENSG00000003756	Chromatin interaction
ENSG00000114353	Chromatin interaction
ENSG00000001617	Chromatin interaction
ENSG00000207922	Chromatin interaction

Extended variants
information (count: 97 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:71)

rs_ID	r²[population]
rs1005678	0.88[ASN][1000 genomes]
rs11130248	0.82[AMR][1000 genomes]
rs12054052	0.97[AMR][1000 genomes];0.84[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs12054403	0.82[AMR][1000 genomes]
rs12485390	0.89[AMR][1000 genomes]
rs12485909	0.91[AMR][1000 genomes];0.85[ASN][1000 genomes]
rs12487392	0.94[AMR][1000 genomes];0.85[ASN][1000 genomes]
rs12488235	0.88[AMR][1000 genomes]
rs12488302	0.88[AMR][1000 genomes]
rs12490809	0.82[AMR][1000 genomes]
rs12491177	0.89[AMR][1000 genomes];0.94[ASN][1000 genomes]
rs12492683	0.88[AMR][1000 genomes]
rs12492880	0.88[AMR][1000 genomes]
rs12493693	0.86[AMR][1000 genomes]
rs12494414	0.86[AMR][1000 genomes]
rs12495261	0.82[AMR][1000 genomes]
rs12496815	0.82[AMR][1000 genomes]
rs12498048	0.89[AMR][1000 genomes]
rs12632110	0.88[ASN][1000 genomes]
rs12721544	0.94[AMR][1000 genomes];0.87[ASN][1000 genomes]
rs2006199	0.88[AMR][1000 genomes]
rs2071203	0.82[AMR][1000 genomes]
rs2071204	0.82[AMR][1000 genomes]
rs2071205	0.82[AMR][1000 genomes]
rs2071801	0.82[AMR][1000 genomes]
rs2072053	0.95[AMR][1000 genomes];0.84[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs2072054	0.95[AMR][1000 genomes];0.84[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2073500	0.82[AMR][1000 genomes]
rs2229647	0.84[AMR][1000 genomes]
rs2236943	0.89[AMR][1000 genomes]
rs2236949	0.82[AMR][1000 genomes]
rs2269430	0.89[AMR][1000 genomes]
rs2269432	0.82[AMR][1000 genomes]
rs2269568	0.82[AMR][1000 genomes]
rs2282750	0.89[AMR][1000 genomes]
rs2285043	0.81[AMR][1000 genomes]
rs2285044	0.82[AMR][1000 genomes]
rs2624838	0.92[ASN][1000 genomes]
rs2624839	0.85[ASN][1000 genomes]
rs35455589	0.82[AMR][1000 genomes]
rs3774736	0.92[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs3774739	0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs3774741	0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs3774748	0.94[AMR][1000 genomes];0.96[ASN][1000 genomes]
rs3774752	0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs3774754	0.85[AMR][1000 genomes]
rs3774755	0.82[AMR][1000 genomes]
rs4141407	0.85[AMR][1000 genomes]
rs4688682	0.89[AMR][1000 genomes]
rs4688683	0.81[AMR][1000 genomes];0.82[ASN][1000 genomes]
rs4688724	0.82[AMR][1000 genomes]
rs4688728	0.81[AMR][1000 genomes]
rs4688732	0.85[AMR][1000 genomes]
rs4688734	0.85[AMR][1000 genomes]
rs4688736	0.82[AMR][1000 genomes]
rs4688738	0.83[AMR][1000 genomes]
rs4688741	0.89[AMR][1000 genomes]
rs4688742	0.89[AMR][1000 genomes]
rs4688743	0.83[AMR][1000 genomes]
rs4688744	0.87[AMR][1000 genomes]
rs4688746	0.94[AMR][1000 genomes];0.89[ASN][1000 genomes]
rs4688747	0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs57944420	0.85[AMR][1000 genomes]
rs57978992	0.89[AMR][1000 genomes]
rs58137261	0.97[AMR][1000 genomes];0.84[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs58191283	0.97[AMR][1000 genomes];0.84[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs60276643	0.94[AMR][1000 genomes];0.84[ASN][1000 genomes]
rs72932959	0.82[AMR][1000 genomes]
rs7645537	0.87[AMR][1000 genomes]
rs9681992	0.81[AMR][1000 genomes]
rs9882618	0.88[AMR][1000 genomes];0.84[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:26 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv834690	chr3:50101835-50267584	Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
2	nsv515986	chr3:50104307-50267584	Bivalent Enhancer Strong transcription Weak transcription Flanking Bivalent TSS/Enh Active TSS Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	nsv432418	chr3:50114496-50224196	Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
4	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
5	nsv876768	chr3:50144951-50267584	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
6	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
7	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
8	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
9	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
10	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
11	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
12	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
13	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
14	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
15	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
16	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
17	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
19	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
20	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
21	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
22	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
23	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
24	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
25	esv3323037	chr3:50190548-50194846	Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	8 gene(s)	inside rSNPs	diseases
26	esv3356010	chr3:50191398-50194246	Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:124 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50191600-50193400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
2	chr3:50191800-50193400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr3:50191800-50193400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
4	chr3:50191800-50193400	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr3:50191800-50193400	Active TSS	Fetal Brain Female	brain
6	chr3:50191800-50193400	Active TSS	Hela-S3	cervix
7	chr3:50191800-50194400	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr3:50192000-50193400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
9	chr3:50192000-50193400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr3:50192000-50193400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
11	chr3:50192000-50193400	Active TSS	K562	blood
12	chr3:50192000-50193600	Active TSS	Aorta	Aorta
13	chr3:50192000-50193600	Active TSS	Small Intestine	intestine
14	chr3:50192000-50193800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
15	chr3:50192000-50194400	Active TSS	Pancreatic Islets	Pancreatic Islet
16	chr3:50192000-50194400	Active TSS	Psoas Muscle	Psoas
17	chr3:50192000-50194800	Active TSS	H9 Cell Line	embryonic stem cell
18	chr3:50192000-50194800	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr3:50192000-50194800	Active TSS	Gastric	stomach
20	chr3:50192000-50194800	Active TSS	Left Ventricle	heart
21	chr3:50192000-50194800	Active TSS	Right Atrium	heart
22	chr3:50192200-50193600	Active TSS	NHLF	lung
23	chr3:50192200-50193800	Active TSS	Ovary	ovary
24	chr3:50192200-50194000	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr3:50192200-50194400	Active TSS	HMEC	breast
26	chr3:50192200-50195000	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr3:50192400-50194400	Active TSS	NHEK	skin
28	chr3:50192400-50194600	Active TSS	ES-WA7 Cell Line	embryonic stem cell
29	chr3:50192400-50195000	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr3:50192600-50193400	Flanking Active TSS	Primary hematopoietic stem cells	blood
31	chr3:50192600-50193400	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr3:50192600-50193400	Active TSS	NHDF-Ad	bronchial
33	chr3:50192600-50193600	Flanking Active TSS	Liver	Liver
34	chr3:50192600-50194600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
35	chr3:50192600-50194800	Transcr. at gene 5' and 3'	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr3:50192600-50194800	Active TSS	Fetal Kidney	kidney
37	chr3:50192800-50193400	Flanking Bivalent TSS/Enh	Primary neutrophils fromperipheralblood	blood
38	chr3:50192800-50193400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr3:50193000-50193400	Flanking Bivalent TSS/Enh	Primary T killer naive cells fromperipheralblood	blood
40	chr3:50193000-50193400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
41	chr3:50193000-50193400	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
42	chr3:50193000-50193400	Flanking Bivalent TSS/Enh	Primary mononuclear cells fromperipheralblood	Blood
43	chr3:50193000-50193400	Flanking Active TSS	Brain Angular Gyrus	brain
44	chr3:50193000-50193400	Flanking Active TSS	Brain Anterior Caudate	brain
45	chr3:50193000-50193400	Active TSS	Colon Smooth Muscle	Colon
46	chr3:50193000-50193400	Active TSS	Fetal Lung	lung
47	chr3:50193000-50193400	Flanking Active TSS	Lung	lung
48	chr3:50193000-50193400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
49	chr3:50193000-50193400	Bivalent/Poised TSS	Stomach Mucosa	stomach
50	chr3:50193000-50193400	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links